查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1623168

电动骨骼生长刺激植入装置的全球市场规模:各产品，各用途，各地区，范围及预测

Global Electrical Bone Growth Stimulators Market Size By Product (External Type, Implanted Type), By Application (Hospitals And Clinics, Home Care, Academic And Research Institutes), By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

电动骨骼生长刺激器的市场规模与预测

2022 年电动骨骼生长刺激器的市场规模价值为 20.4 亿美元，预计到 2030 年将达到 33 亿美元，2023 年至 2030 年的复合年增长率为 5.3%。人们对非侵入性和微创手术治疗的偏好日益增加是推动电骨生长刺激器市场收入成长的关键因素，而不断增长的目标患者群体将推动市场成长。全球电动骨骼生长刺激器市场报告对市场进行了全面的评估。它对关键细分市场、趋势、市场推动因素、阻碍因素、竞争格局以及在市场中发挥关键作用的因素进行了全面的分析。

全球电动骨骼生长刺激器市场的定义

骨骼生长刺激器 (BGS) 是医疗产业用来辅助骨折癒合过程的设备。 BGS 透过向骨骼输送适量的电流，刺激最新的细胞群并使骨折更快癒合，从而增强此过程。刺激器通常用于治疗难以治疗的骨折、不癒合以及舟骨、胫骨远端、股骨、肱骨和第五跖骨干的应力性骨折。

骨骼生长刺激透过纤维软骨的钙化和矿化增强骨形成环境，修復骨折部位并改善血管分布。儘管医疗保健提供者明白骨癒合可能很复杂或受损，似乎有理由使用骨骼刺激器，但现有研究尚未证明其在某些情况下的使用是有效的。

全球电动骨骼生长刺激器市场概况

肥胖率上升和骨科损伤增多是电骨骼生长刺激器市场扩张的主要驱动力。非侵入性医疗程序的兴起提高了骨移植手术的成功率，且副作用风险较低，预计也将推动对 BGS 的需求。与其他侵入性治疗技术相比，BGS 的併发症发生率较低。

机车使用者的快速增加也将促使脊椎损伤的道路交通事故大幅增加，最终推动电骨骼生长刺激器市场的扩张。然而，对BGS成功率的了解不足和高昂的治疗费用是骨骼生长刺激器发展的主要抑制因素。此外，对安全、创新、现代和有效的治疗技术的需求不断增加，可能为电骨骼生长刺激器市场创造机会。

目录

第1章 电动骨骼生长刺激植入装置的全球市场简介

  • 市场概要
  • 调查范围
  • 前提条件

第2章 摘要整理

第3章 VERIFIED MARKET RESEARCH的调查手法

  • 资料探勘
  • 验证
  • 第一手资料
  • 资料来源一览

第4章 电动骨骼生长刺激植入装置的全球市场展望

  • 概要
  • 市场动态
    • 促进因素
    • 阻碍因素
    • 机会
  • 波特的五力分析
  • 价值链分析

第5章 电动骨骼生长刺激植入装置的全球市场:各产品

  • 概要
  • 外置类型
  • 嵌入式类型

第6章 电动骨骼生长刺激植入装置的全球市场:各用途

  • 概要
  • 医院和诊疗所
  • 居家医疗
  • 学术·研究机关

第7章 电动骨骼生长刺激植入装置的全球市场，各地区

  • 概要
  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 其他欧洲
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 全球其他地区
    • 南美
    • 中东·非洲

第8章 电动骨骼生长刺激植入装置的全球市场:竞争情形

  • 概要
  • 企业市场排行榜
  • 主要的开发策略

第9章 企业简介

  • Stryker
  • ITO
  • Orthofix Medical
  • Zimmer Biomet

第10章 附录

  • 相关报告
简介目录
Product Code: 16315

Electrical Bone Growth Stimulators Market Size And Forecast

Electrical Bone Growth Stimulators Market size was valued at USD 2.04 Billion in 2022 and is projected to reach USD 3.3 Billion by 2030 , growing at a CAGR of 5.3% from 2023 to 2030. The growing preference for non-invasive and minimally invasive surgical treatments is the crucial aspect of the rise in the market revenue of Electrical Bone Growth Stimulators, and the increasing target patient population will foster market growth. The Global Electrical Bone Growth Stimulators Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Electrical Bone Growth Stimulators Market Definition

Bone growth stimulator (BGS) is a device utilized in the medical industry for the healing process of a fracture. BGS enhances this process by stimulating the assembly of the latest cells by applying the right amount of electricity to the bone, allowing the fracture to heal considerably faster. Stimulators are usually employed for hard-to-treat fractures, nonunions, and inadequately healing stress fractures of the scaphoid, distal tibia, femur, humerus, and fifth metatarsal shaft.

The bone growth stimulation leads to an enhanced osteogenic environment with calcification and mineralization of the fibrocartilage repairs the fracture site and improves vascularity. Although a healthcare provider's understanding that bone healing could also be complicated or impaired would seemingly justify the utilization of a bone stimulator, the existing research has not illustrated that the utilization of a bone stimulator under certain circumstances is effective.

Global Electrical Bone Growth Stimulators Market Overview

The rise in obesity and hence the increase in the number of orthopedic injuries are the main driving factors for the expansion of the Electrical Bone Growth Stimulators Market. The rise in non-invasive medical practices to reinforce the success of bone grafting procedures and the low risk of adverse effects also are expected to accelerate the demand for BGS. The complexity rates in BGS are low as compared to other invasive medical treatment techniques.

The rapid rise in automobile users also leads to a substantial rise in road accidents resulting in spinal injuries and therefore eventually promoting the expansion of the Electrical Bone Growth Stimulators Market. However, inadequate knowledge about the success rates of BGS and therefore the higher treatment cost are the main restraints within the growth of the bone growth stimulator. Moreover, the increasing demand for safe, innovative, and modern effective treatment techniques can create a chance for the Electrical Bone Growth Stimulators Market.

Global Electrical Bone Growth Stimulators Market: Segmentation Analysis

The Global Electrical Bone Growth Stimulators Market is Segmented on the basis of Product, Application, And Geography.

Electrical Bone Growth Stimulators Market, By Product

  • External Type
  • Implanted Type

Based on Product, the market is bifurcated into External Type and Implanted Type. The external type segment is expected to account for the largest market share in the estimated period. This can primarily be attributed to the growing aging population globally, the rising preference for non-surgical treatment procedures, and therefore the growing prevalence of nonunion fractures.

Electrical Bone Growth Stimulators Market, By Application

  • Hospitals and Clinics
  • Home Care
  • Academic and Research Institutes

Based on Application, the market is bifurcated into Hospitals and Clinics, Home Care, and Academic and Research Institutes. The hospitals and clinics segment accounted for the most important of the market. The advantages of bone growth stimulation products over their counterparts are the key factor driving their adoption during this end-user segment.

Electrical Bone Growth Stimulators Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world
  • On the basis of Regional Analysis, The Global Electrical Bone Growth Stimulators Market is classified into North America, Europe, Asia Pacific, and Rest of the world. The U.S. drives the expansion within the North American region as it is the largest market within the region. The Asia-Pacific region offers considerable potential for market growth attributable to the rapid climb in markets such as India and China. The APAC region is projected to experience growth at the highest CAGR.

Key Players

  • The "Global Electrical Bone Growth Stimulators Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
  • Stryker, ITO, Orthofix Medical, Zimmer Biomet.
  • The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

  • Partnerships, Collaborations and Agreements
  • In April 2021, Orthofix Medical Inc., an international medical device firm, announced that it has entered into a formal license deal to commercialize the revolutionary portfolio of IGEA S.p. A's bone and soft tissue stimulation products in the United States and Canada. With this agreement, the firm gains the authority to obtain US Food and Drug Administration clearances for IGEA's orthopedic product platform.
  • Orthofix signed an exclusive license agreement in 2021 to commercialize IGEA's revolutionary array of bone, cartilage, and soft tissue stimulation solutions in the United States and Canada.
  • DePuy Synthes renewed its cooperation with the AO Foundation in 2020 to improve patient care and outcomes through innovation and the AO Foundation's independent worldwide education initiatives.
  • Mergers and Acquisitions
  • Stryker paid USD 5.4 billion for Wright Medical in 2020. Stryker's position in the orthopedics device industry was reinforced as a result of the acquisition.
  • Medtronic plc announced in January 2020 that it had acquired Stimgenics, LLC, a privately held business that has developed a unique spinal cord stimulation (SCS) therapy. This therapy is given via the Medtronic Intellis platform and is a new and exclusive programming option for treating chronic pain patients.
  • In February 2019, Colfax Corporation paid $3.15 billion to acquire DJO Global Inc. from an investment group led by private equity funds managed by Blackstone. With this acquisition, Colfax Corporation intends to achieve significant development in the orthopedic solutions industry.
  • Product Launches and Product Expansions
  • Orthofix Medical Inc., a medical device firm, announced the FDA approval of the STIM Ontrack mobile app version to be utilized by the company's bone growth stimulators in February 2020. This technology works in conjunction with the Orthofix bone growth therapy devices to help patients adhere to their prescriptions and advance their clinical results.
  • Orthofix International N.V. releases its next-generation bone growth stimulators, Cervical-Stim and Spinal-Stim, in April 2017. These gadgets are intended to encourage and boost the body's natural healing process following a spinal fusion operation.

TABLE OF CONTENTS

1. INTRODUCTION OF GLOBAL ELECTRICAL BONE GROWTH STIMULATORS MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4. GLOBAL ELECTRICAL BONE GROWTH STIMULATORS MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5. GLOBAL ELECTRICAL BONE GROWTH STIMULATORS MARKET, BY PRODUCT

  • 5.1 Overview
  • 5.2 External Type
  • 5.3 Implanted Type

6. GLOBAL ELECTRICAL BONE GROWTH STIMULATORS MARKET, BY APPLICATION

  • 6.1 Overview
  • 6.2 Hospitals and Clinics
  • 6.3 Home Care
  • 6.4 Academic and Research Institutes

7. GLOBAL ELECTRICAL BONE GROWTH STIMULATORS MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Rest of the World
    • 7.5.1 Latin America
    • 7.5.2 Middle East & Africa

8. GLOBAL ELECTRICAL BONE GROWTH STIMULATORS MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Ranking
  • 8.3 Key Development Strategies

9. Company Profiles

  • 9.1 Stryker
    • 9.1.1 Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Outlook
    • 9.1.4 Key Developments
  • 9.2 ITO
    • 9.2.1 Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Outlook
    • 9.2.4 Key Developments
  • 9.3 Orthofix Medical
    • 9.3.1 Overview
    • 9.3.2 Financial Performance
    • 9.3.3 Product Outlook
    • 9.3.4 Key Developments
  • 9.4 Zimmer Biomet
    • 9.4.1 Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Outlook
    • 9.4.4 Key Developments

10. Appendix

  • 10.1 Related Reports